Trokos

Home › Outcome measures › Hip

Outcome measures for hip pain

Hip questionnaires that meet our evidence standard, with their reliability and the smallest change that matters. How these were chosen.

Figures describe groups, not one patient. Each figure comes from a particular group of patients and a particular version and language of the questionnaire. A change in one patient’s score that is smaller than the measurement error may be noise rather than real change.

At a glance

  • No hip questionnaire has been tested well on every measurement property: a 2020 international consensus on hip-related pain in young and middle-aged active adults found that none showed acceptable quality across all properties.2
  • Young and middle-aged active adults with hip or groin pain: the HAGOS (Copenhagen Hip and Groin Outcome Score) and the iHOT (International Hip Outcome Tool, long and short versions) were named the most appropriate by that consensus,2 and a 2015 review using COSMIN (the consensus-based standards for the selection of health measurement instruments) also recommended the HOS (Hip Outcome Score).1 They are rated within that group. For the HAGOS, four of five studies found the detectable change for one person larger than the important change; the fifth (Swedish) cannot be compared subscale by subscale. For the iHOT-33 the detectable change for one person is larger than the important change.
  • Gluteal tendinopathy: the VISA-G (Victorian Institute of Sport Assessment, gluteal) is the preferred available questionnaire, according to a 2022 review;22 a 2021 review found moderate-quality evidence of sufficient reliability and measurement error but said further validation is needed.21
  • Hip replacement: the Oxford Hip Score, the HOOS (Hip disability and Osteoarthritis Outcome Score) and the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) are supported by reviews in people having hip replacement;26,27 the Forgotten Joint Score is supported by a review in people after joint replacement.42 Important changes for the HOOS have also been measured in hip osteoarthritis treated with exercise.35
  • The modified Harris Hip Score is not listed: a 2015 review could not fully evaluate it, and the 2020 consensus recommended other questionnaires.1,2

How these were chosenThe rule for which questionnaires are listed, and how licensed ones are handled.

To be listed here, a questionnaire must be supported by a systematic review of its measurement properties in people with hip problems, or be recommended in an international core outcome set for hip problems (a full recommendation, not interim use), and its reliability and smallest important change must be published. Where a review grades the quality of the reliability evidence, it must be at least low quality. A questionnaire built for one condition (for example, rotator cuff disease) is judged within that condition, and its entry says so. Questionnaires that need a licence are named and described, with a link to the official copy where the owner allows it; their questions are not reproduced. Open any heading for the figures and sources.

The same rule is used on every region page; see the outcome measures home page.

How to read the figuresWhat reliability, the smallest change that matters and measurement error mean, and how the evidence is rated.

Reliability (intraclass correlation coefficient, ICC): how closely the scores agree when a patient whose condition has not changed fills in the questionnaire twice. The closer to 1, the closer the agreement; the quality criteria used in COSMIN reviews (COSMIN: the consensus-based standards for the selection of health measurement instruments) count 0.70 or more as sufficient.47

Smallest change that matters (minimal important change, MIC): the smallest change in one patient’s score that patients see as a real improvement or worsening. Some studies call a similar figure the minimal clinically important difference (MCID) or clinically important difference; this page uses the term each source uses. Estimates vary between studies, so treat them as a guide.40

Measurement error (smallest or minimal detectable change, SDC or MDC): the smallest change that is larger than the questionnaire’s own error. The same quality criteria count measurement error as sufficient only when the smallest important change is larger than the smallest detectable change.47

Evidence rating on this page: Strong means a systematic review found high-quality (or strong) evidence that reliability is sufficient, no review contradicts it, and the published smallest detectable change is smaller than the smallest important change. Moderate means a systematic review, or a national evidence review, rated reliability as sufficient on moderate-quality evidence, or several reviews consistently report sufficient reliability without formally grading the evidence. Where reviews or studies disagree (on reliability or on measurement error), the rating is Moderate and the disagreement is stated. Low means, with no review or study disagreeing, that reliability or measurement error in the main patient group on this page (here, adults with hip problems) was low quality or insufficient (for example, the smallest detectable change is as large as, or larger than, the smallest important change), or that the support comes only from a narrower group of patients. If the Low test is met, the rating is Low even where reliability alone would be Moderate. A questionnaire built for one condition (for example, rotator cuff disease) is rated within that condition, and its entry says so. Each questionnaire gives the reason for its rating.

Each figure names its source by number (see Sources) and says whether it was checked against the full paper or only the abstract.

Questionnaires that meet the standard (9)Four for young and middle-aged active adults with hip or groin pain, one for gluteal tendinopathy, and four for hip osteoarthritis or hip replacement.
Copenhagen Hip and Groin Outcome Score (HAGOS)Six subscales for young to middle-aged, physically active people with long-standing hip or groin pain; recommended by a review and an international consensus, but its detectable change for one person is larger than its important change.

Evidence: Low, rated within young to middle-aged active adults with hip or groin pain, the group it was built for (measurement error insufficient). A 2015 COSMIN review found adequate test-retest reliability, construct validity, responsiveness and interpretability for young to middle-aged adults with hip pain treated with or without surgery, and found it the only questionnaire also aimed at groin pain;1 a 2020 international consensus named it, with the iHOT, as the most appropriate questionnaire for young and middle-aged active adults with hip-related pain.2 For one person, the smallest detectable change was 17.7 to 33.8, 18.3 to 34.1, 16.71 to 30.9 and 11.6 to 19.8 points across the subscales in four studies,3,6,7,8 in three of them wholly larger than every subscale’s important change (1.0 to 12.1 points, listed in a 2026 review),49 and in the Turkish study larger for all but possibly one subscale (its abstract does not say which subscale the lowest figure, 11.6, belongs to). A Swedish study reported 7.8 to 16.1 points; its abstract does not show which subscale each figure belongs to, so it cannot be compared subscale by subscale.5

What it measuresSymptoms, pain, physical function in daily living, physical function in sport and recreation, participation in physical activities, and hip and/or groin-related quality of life, in young to middle-aged, physically active people with long-standing hip and/or groin pain.3 (source 3, abstract source only)
Tested inPhysically active adults with long-standing hip and/or groin pain (development study, 101 people);3 people 12 to 24 months after hip arthroscopy;4 people with femoroacetabular impingement (Swedish version, 502 people);5 middle-aged people with hip complaints (Dutch version);6 athletes and physically active people with hip and groin pain (Brazilian version);7 people with hip osteoarthritis (Turkish version);8 and people with hip-abductor tendon problems.9 (source 3, abstract source only; source 4, abstract source only; source 5, abstract source only; source 6, full paper; source 7, abstract source only; source 8, abstract source only; source 9, abstract source only)
Items and scoringSix separate subscales,3 answered on a 5-point scale; each subscale’s sum is converted to a 0 to 100 scale, where a higher score means less pain and disability.6 (source 3, abstract source only; source 6, full paper)
Free or licensedLicence terms not confirmed: we found no page from the owner stating them, so no link is given.
ReliabilityReliability (ICC) 0.82 to 0.91 across the six subscales in the development study.3 (source 3, abstract source only) Reliability (ICC) 0.81 to 0.87 (Swedish version),5 (source 5, abstract source only) 0.80 and higher (Dutch version),6 (source 6, full paper) 0.81 to 0.94 (Brazilian version)7 (source 7, abstract source only) and 0.836 to 0.936 in hip osteoarthritis (Turkish version).8 (source 8, abstract source only) After hip arthroscopy, all five questionnaires tested, including the HAGOS, had reliability (ICC) between 0.91 and 0.97; the abstract does not give each questionnaire’s figure.4 (source 4, abstract source only)
Smallest change that matters (MIC)Minimal important change by subscale, from studies after hip arthroscopy listed in a 2026 review: symptoms 8.4, pain 9.1, daily living 9.0, sport and recreation 9.0, participation in physical activities 12.1 in one study and 1.0 in the other (listed as “physical activity”), quality of life 9.0 points.49 (source 49, full paper) After hip arthroscopy, the minimal important change was under 11 points (out of 100) for each of the five questionnaires tested, including the HAGOS.4 (source 4, abstract source only)
Measurement errorSmallest detectable change for one person 17.7 to 33.8 points across the subscales (2.7 to 5.2 for a group) in the development study;3 (source 3, abstract source only) 7.8 to 16.1 for one person (1.6 to 3.2 for a group) in the Swedish version;5 (source 5, abstract source only) minimal detectable change 18.3 to 34.1 for one person (2.3 to 4.4 for a group) in the Dutch version;6 (source 6, full paper) smallest detectable change 16.71 to 30.9 in the Brazilian version;7 (source 7, abstract source only) and minimal detectable change 11.6 to 19.8 for one person (1.60 to 2.74 for a group) in hip osteoarthritis.8 (source 8, abstract source only)

After hip arthroscopy, some HAGOS subscales had reduced measurement properties, and the daily-living subscale showed a ceiling effect.4 (source 4, abstract source only)

In 210 people with hip-abductor tendon problems, three of the original HAGOS subscales did not fit their intended structure, while a revised scoring format fitted adequately.9 (source 9, abstract source only)

International Hip Outcome Tool, 33-item version (iHOT-33)Thirty-three questions on quality of life for young, active people with hip problems; recommended by reviews and an international consensus, but its detectable change for one person is larger than its important change.

Evidence: Low, rated within young, active adults with hip problems, the group it was built for (measurement error insufficient). Reviews report adequate reliability without formally grading the overall evidence: a 2015 COSMIN review recommended it,1 a 2015 review of hip preservation surgery rated it the best of the tools it reviewed,48 and a 2020 international consensus named the iHOT among the most appropriate questionnaires.2 The detectable change for one person (14.2 and 16.7 points) was larger than the important change in the same study (10.9 and 10.7 points, both distribution-based: half a standard deviation);13,50 the Italian figure (24.8) is also larger than the development study’s important change (6 points).12,10

What it measuresHealth-related quality of life in young, active people with hip disorders, in four areas: symptoms and functional limitations; sports and recreational activities; job-related concerns; and social, emotional and lifestyle concerns.10 (source 10, abstract source only)
Tested inActive people aged 18 to 60 with a variety of hip conditions (development study);10 people 12 to 24 months after hip arthroscopy;4 278 people with hip and/or groin pain who were not seeking surgery;11 adults with musculoskeletal hip pain (Italian version, 117 people);12 people with various hip disorders (Thai version);13 and young, active people with hip joint pain (Dutch version).50 (source 10, abstract source only; source 4, abstract source only; source 11, abstract source only; source 12, abstract source only; source 13, full paper; source 50, full paper)
Items and scoring33 items in four domains (16, 6, 4 and 7 items). Each is answered on a visual analogue scale and scored 0 to 100; the total is the average of the answered questions, and a higher score means better function and fewer symptoms.13 (source 13, full paper)
Free or licensedLicence terms not confirmed: we found no page from the owner stating them, so no link is given.
ReliabilityReliability (ICC) 0.78 in the development study (123 people), reported during item reduction; the abstract does not say whether it applies to the final 33-item version.10 (source 10, abstract source only) Reliability (ICC) 0.83 (Thai version)13 (source 13, full paper) and 0.92 (Dutch version).50 (source 50, full paper) Reliability (ICC) 0.78 to 0.88 for the total and subscale scores in people not seeking surgery; none reached the 0.90 the authors required for use with individual patients.11 (source 11, abstract source only) Reliability (ICC) 0.806 (Italian version).12 (source 12, abstract source only) After hip arthroscopy, all five questionnaires tested, including the iHOT-33, had reliability (ICC) between 0.91 and 0.97; the abstract does not give each questionnaire’s figure.4 (source 4, abstract source only)
Smallest change that matters (MIC)Minimal clinically important difference 6 points in the development study (responsiveness tested in 27 people after arthroscopy).10 (source 10, abstract source only) Minimal important change 10.9 points (half a standard deviation, Thai version)13 (source 13, full paper) and 10.7 points (half a standard deviation, Dutch version).50 (source 50, full paper) After hip arthroscopy, the minimal important change was under 11 points (out of 100) for each of the five questionnaires tested, including the iHOT-33.4 (source 4, abstract source only)
Measurement errorSmallest detectable change for one person 14.2 points (Thai version)13 (source 13, full paper) and 16.7 points (Dutch version).50 (source 50, full paper) Minimal detectable change (95% confidence) 24.8 points for one person (Italian version).12 (source 12, abstract source only) Minimal detectable change 2.3 to 3.7 points at group level in people not seeking surgery; a group-level figure cannot be compared with one person’s important change.11 (source 11, abstract source only)

In people not seeking surgery, the job subscale did not meet the authors’ reliability or responsiveness criteria (when no treatment was given).11 (source 11, abstract source only)

International Hip Outcome Tool, 12-item version (iHOT-12)The short form of the iHOT-33, made for routine clinical practice; high reliability, but its detectable change for one person is larger than its important change.

Evidence: Low, rated within young, active adults with hip problems, the group it was built for (measurement error insufficient). A 2015 COSMIN review found adequate test-retest reliability, construct validity, responsiveness and interpretability,1 and a 2020 international consensus named the iHOT among the most appropriate questionnaires.2 In two studies the detectable change for one person (22.8 and 17.22 points)12,17 was larger than the important changes reported elsewhere (13.0 and 13.79 points).16,15 A Japanese study reported 3.19 points, but its abstract does not say whether this is for one person or a group; its size suggests a group figure, so it is not used.51

What it measuresThe same areas as the iHOT-33 in 12 of its items, for use in routine clinical practice; it captured 95.9% of the variation in iHOT-33 scores.14 (source 14, abstract source only)
Tested inPeople with hip disorders (development 104 people, validation 1,833 people);14 active people with a hip disorder (German version, 83 people);15 people having hip arthroscopy for femoroacetabular impingement (120 people);16 physically active people with labral tears or femoroacetabular impingement (Spanish version);17 adults with musculoskeletal hip pain (Italian version);12 people with femoroacetabular impingement (Japanese version);51 and people having hip arthroscopy for femoroacetabular impingement (French version).52 (source 14, abstract source only; source 15, full paper; source 16, abstract source only; source 17, full paper; source 12, abstract source only; source 51, abstract source only; source 52, abstract source only)
Items and scoring12 items, each marked on a 100 mm visual analogue scale from 0 (greater impairment) to 100 (no problems); the score is the average of the answered questions, and a higher score means better physical function and quality of life.17 (source 17, full paper)
Free or licensedLicence terms not confirmed: we found no page from the owner stating them, so no link is given.
ReliabilityReliability (ICC) 0.94 (95% confidence interval 0.89 to 0.97) in 46 people (German version).15 (source 15, full paper) Reliability (ICC) 0.830 (Italian version).12 (source 12, abstract source only) Reliability (ICC) 0.93 (95% confidence interval 0.86 to 0.94; Spanish version).17 (source 17, full paper) Reliability (ICC) 0.89 (Japanese version, 50 people)51 (source 51, abstract source only) and 0.84 (French version, 101 people).52 (source 52, abstract source only)
Smallest change that matters (MIC)Minimal clinically important difference 13.0 points (distribution-based) one year after hip arthroscopy for femoroacetabular impingement.16 (source 16, abstract source only) Minimal important change 13.79 points (half a standard deviation) in the German version.15 (source 15, full paper) Minimal important change 12.40 points (Japanese version).51 (source 51, abstract source only) Minimal clinically important difference 11 points (French version).52 (source 52, abstract source only)
Measurement errorMinimal detectable change (95% confidence) 22.8 points (Italian version)12 (source 12, abstract source only) and 17.22 points (Spanish version).17 (source 17, full paper) The German study reports a smallest detectable change of 2.76, but it divided by the square root of the sample size, so this is a figure for a group, not one person, and it is not compared with the important change.15 (source 15, full paper) The French figure (1.8, with a standard error of measurement of 6.7) fits the same group-level calculation, so it is not used either.52 (source 52, abstract source only) Smallest detectable change 3.19 points (Japanese version); the abstract does not say whether this is for one person or a group, and its size suggests a group figure, so it is not used.51 (source 51, abstract source only)
Hip Outcome Score (HOS)Two subscales (activities of daily living and sports) used after hip arthroscopy; studies disagree on whether its measurement error is smaller than its important change.

Evidence: Moderate, rated within adults having hip arthroscopy, the group it was built for (studies disagree on measurement error). A 2015 COSMIN review found adequate test-retest reliability, construct validity, responsiveness and interpretability, but not adequate content validity.1 In a 2008 study after hip arthroscopy the detectable change (3 points) was smaller than the important change (9 and 6 points);18 in the Dutch version it was larger (21 and 29 points against 14 and 11).20

What it measuresSelf-reported function in activities of daily living and in sport, to evaluate the outcomes of treatment for hip problems.18,19 (source 18, abstract source only; source 19, full paper)
Tested inPeople having hip arthroscopy (126 people);18 Spanish version;19 and people having hip arthroscopy for femoroacetabular impingement syndrome (Dutch version).20 (source 18, abstract source only; source 19, full paper; source 20, full paper)
Items and scoringTwo subscales: activities of daily living (19 items) and sports (9 items), each item with five response options from “unable to do” to “no difficulty”. Each subscale is converted to 0 to 100, where a higher score means better function.19 (source 19, full paper)
Free or licensedLicence terms not confirmed: we found no page from the owner stating them, so no link is given.
ReliabilityReliability (ICC) 0.98 for daily living and 0.92 for sports after hip arthroscopy.18 (source 18, abstract source only) Reliability (ICC) 0.86 for daily living and 0.81 for sports (Dutch version).20 (source 20, full paper)
Smallest change that matters (MIC)Minimal clinically important difference 9 points (daily living) and 6 points (sports).18 (source 18, abstract source only) Minimal clinically important difference 14 points (daily living) and 11 points (sports) in the Dutch version.20 (source 20, full paper)
Measurement errorMinimal detectable change 3 points (plus or minus) for both subscales, smaller than the important change in the same study (the abstract does not say how this was calculated).18 (source 18, abstract source only) Smallest detectable change 21 points (daily living) and 29 points (sports) in the Dutch version, larger than the important change in the same study.20 (source 20, full paper)

After hip arthroscopy, the HOS had reduced measurement properties and its daily-living subscale showed a ceiling effect.4 (source 4, abstract source only)

In gluteal tendinopathy, a 2022 COSMIN review found only very low-quality evidence for the HOS.22 (source 22, abstract source only)

Victorian Institute of Sport Assessment, gluteal (VISA-G)Built for gluteal tendinopathy (greater trochanteric pain syndrome) and rated within that condition; the preferred available questionnaire for it, according to a 2022 review.

Evidence: Moderate, rated within gluteal tendinopathy (greater trochanteric pain syndrome), the condition it was built for (reviews differ on the quality of the evidence). We count this difference in the quality grade as a disagreement on reliability and measurement error, so the rating is Moderate rather than Low. A 2021 COSMIN review found moderate-quality evidence that its reliability and its measurement error are sufficient, with the detectable change (about 4 points; range 3.17 to 5.2) smaller than the important change (29 points); its studies included people without symptoms as well as patients;21 a 2022 COSMIN review rated the evidence for sufficient reliability and measurement error as low quality, and called the VISA-G the preferred available option for gluteal tendinopathy.22 The only important change we found comes from people after hip abductor tendon repair surgery.23

What it measuresPain-related disability in gluteal tendinopathy: pain, everyday activities, physical activities and difficulty with weight-bearing activities.24 (source 24, full paper)
Tested inPatients and people without symptoms in three studies (239 people);21 six studies of people with gluteal tendinopathy;22 people with greater trochanteric pain syndrome (Norwegian version, 78 people);24 and 56 people having hip abductor tendon repair.23 (source 21, full paper; source 22, abstract source only; source 24, full paper; source 23, abstract source only)
Items and scoring8 questions: questions 1 to 7 are scored 0 to 10 and question 8 is scored 0 to 30, giving a total of 0 to 100. A higher score means less disability.24 (source 24, full paper)
Free or licensedFree to use, according to a 2021 review;21 we found no page from the owner to confirm this, so no link is given. (source 21, full paper)
ReliabilityReliability (ICC) 0.827 to 0.99 across three studies, moderate-quality evidence (2021 review).21 (source 21, full paper) Reliability (ICC) 0.85 (95% confidence interval 0.68 to 0.92) in the Norwegian version.24 (source 24, full paper)
Smallest change that matters (MIC)Minimal clinically important change 29 points (out of 100) after hip abductor tendon repair.23 (source 23, abstract source only)
Measurement errorSmallest detectable change 3.17 to 5.2 points across three studies; the review says a change greater than 4.0 points is a true change (moderate-quality evidence, 2021 review).21 (source 21, full paper) Smallest detectable change (95% confidence) 18.4 points in the Norwegian version.24 (source 24, full paper)

The 2024 international core outcome set for gluteal tendinopathy found that no measure had adequate measurement properties for the core set; it chose interim measures and recommended that the VISA-G be considered in clinical trials.25 (source 25, abstract source only)

Oxford Hip Score (OHS)Twelve questions on hip pain and daily activities, best known for hip replacement; the detectable change was smaller than the important change in two studies. Licensed through Oxford University Innovation.

Evidence: Moderate, rated within people having hip replacement, the group it was built for (a review found some good evidence for its reproducibility). That review used its own three-level scale; we treated its middle grade (some good evidence in favour) as moderate. A 2016 review of hip and knee replacement questionnaires found the Oxford Hip Score had the most complete evidence for hip replacement, grading the evidence for its reproducibility as some good evidence in favour;26 a 2018 COSMIN review of hip replacement questionnaires found it among the most frequently assessed.27 In two studies the detectable change was smaller than the important change (5 against 8 points;28 5.5 against 7.0 points).30

What it measuresHip pain and activities of daily living; a patient self-completion questionnaire.32 (source 32, full page)
Tested inPeople having hip replacement in the NHS patient-reported outcomes programme in England and Wales;28 people having hip replacement (German version, 105 people);29 people with hip osteoarthritis (Spanish version, 361 people);30 and people 12 and 24 months after hip replacement at one hospital.31 (source 28, full paper; source 29, abstract source only; source 30, abstract source only; source 31, abstract source only)
Items and scoring12 items with five response categories, each now scored 0 to 4; the total ranges from 0 (worst) to 48 (best).28 The owner describes a single summed score.32 (source 28, full paper; source 32, full page)
Free or licensedLicence needed from Oxford University Innovation.32 Its general rule is that licences are free for strictly non-commercial academic use and for publicly funded healthcare use; to find out whether a fee applies to any other use, the user completes the licence request.33 Official copy and licence (Oxford University Innovation) (source 32, full page; source 33, full page)
ReliabilityReliability (ICC) 0.90 (German version).29 (source 29, abstract source only) Reliability (ICC) 0.992 (Spanish version).30 (source 30, abstract source only)
Smallest change that matters (MIC)Minimal important change 8 points for one patient (about 11 for a group) after hip replacement.28 (source 28, full paper) Minimal clinically important difference 7.0 points in hip osteoarthritis (Spanish version).30 (source 30, abstract source only) Minimal important change 6.3 points at 12 months and 5.2 points at 24 months after hip replacement.31 (source 31, abstract source only)
Measurement errorMinimal detectable change (90% confidence, distribution-based) about 5 points.28 (source 28, full paper) Minimal detectable change 5.5 points (Spanish version).30 (source 30, abstract source only)

In 210 people with hip-abductor tendon problems, the Oxford Hip Score did not fit its intended structure; the authors say it would need slight adjustment before use in that group.9 (source 9, abstract source only)

Hip disability and Osteoarthritis Outcome Score (HOOS)Five subscales built on the WOMAC for people with hip problems, with or without osteoarthritis; reliable, but its detectable change for one person is larger than its important change.

Evidence: Low (measurement error insufficient). A 2016 review graded the evidence for its reproducibility as some good evidence in favour,26 and a 2018 COSMIN review of hip replacement questionnaires ranked it second, after the WOMAC.27 But in hip osteoarthritis the detectable change for one person (12.0 to 26.2 points across the subscales)34 and in a Turkish study (14.0 to 18.6 points)53 was larger than the important change found in another study (6 to 10 points).35

What it measuresPain, symptoms, function in daily living, function in sport and recreation, and hip-related quality of life.34 It was developed from the WOMAC for people with hip disability with or without hip osteoarthritis.54 (source 34, full paper; source 54, abstract source only)
Tested inPeople with osteoarthritis having hip replacement (Polish version, 157 people);34 people with hip osteoarthritis after 12 weeks of exercise (160 people);35 and people 12 to 24 months after hip arthroscopy.4 (source 34, full paper; source 35, abstract source only; source 4, abstract source only)
Items and scoring40 items in five subscales (pain 10, symptoms 5, daily living 17, sport and recreation 4, quality of life 4), each answered from 0 (best) to 4 (worst). Each subscale is converted to 0 (extreme problems) to 100 (no problems).34 (source 34, full paper)
Free or licensedCopyright held by Professor Ewa Roos; permission is always required. Free for funded and non-funded academic users; fees depend on the type of user for others (from non-profit healthcare to commercial users). Requests go through Mapi Research Trust.36 Official information and permission (koos.nu) (source 36, full page)
ReliabilityReliability (ICC) 0.82 for pain and 0.91 to 0.96 for the other subscales (Polish version).34 (source 34, full paper) After hip arthroscopy, all five questionnaires tested, including the HOOS, had reliability (ICC) between 0.91 and 0.97; the abstract does not give each questionnaire’s figure.4 (source 4, abstract source only)
Smallest change that matters (MIC)Minimal important change 6 to 10 points across the five subscales (out of 100) in hip osteoarthritis after 12 weeks of exercise.35 (source 35, abstract source only) After hip arthroscopy, the minimal important change was under 11 points for each of the five questionnaires tested, including the HOOS.4 (source 4, abstract source only)
Measurement errorMinimal detectable change 12.0 to 26.2 points for one person (1.4 to 3.0 for a group) across the subscales (Polish version).34 (source 34, full paper) Minimal detectable change (95% confidence) 14.0 to 18.6 points across the subscales in hip osteoarthritis (Turkish version).53 (source 53, full paper)

The HOOS physical function short form (HOOS-PS) is a different questionnaire; see Not included.

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Twenty-four questions on pain, stiffness and physical function in hip or knee osteoarthritis; rated highest in a review of hip replacement questionnaires, but important-change estimates vary widely. Licensed; a 2011 review reports that fees apply.

Evidence: Moderate, rated within osteoarthritis and joint replacement, the groups it was built for and tested in (a review found some good evidence for its reproducibility in hip patients). That review used its own three-level scale; we treated its middle grade (some good evidence in favour) as moderate. A 2016 review graded the evidence for its reproducibility in hip patients as some good evidence in favour;26 a 2018 COSMIN review of hip replacement questionnaires found it had the most properties with positive evidence (five) and rated it the highest-quality instrument overall.27 We found no detectable change for hip problems to compare with its important change. A 2019 review found its important-change estimates after hip replacement varied so widely that it was unclear whether they can be applied with confidence.40

What it measuresPain, joint stiffness and physical function (disability) in knee and hip osteoarthritis.37,41 (source 37, full paper; source 41, full page)
Tested inPeople with knee and hip osteoarthritis;37 people with hip osteoarthritis in Turkish (44 people with hip osteoarthritis) and Greek versions;38,39 and people after hip replacement (13 studies in a 2019 review, including knee replacement).40 (source 37, full paper; source 38, abstract source only; source 39, abstract source only; source 40, abstract source only)
Items and scoring24 items in three subscales: pain (5 items), stiffness (2) and physical function (17). Available in 5-point Likert, 100 mm visual analogue and 11-box numerical rating formats; in the Likert version the subscales score 0 to 20, 0 to 8 and 0 to 68. Higher scores mean worse pain, stiffness or function. Recall period 48 hours.37,41 (source 37, full paper; source 41, full page)
Free or licensedPermission is needed and licence fees apply; licensing and fee information comes from a request to the developer, according to a 2011 review.37 The developer’s web page states no licence terms.41 Developer’s WOMAC page (source 37, full paper; source 41, full page)
ReliabilityReliability (ICC) 0.77 to 0.94 across the subscales in hip osteoarthritis (Turkish version)38 (source 38, abstract source only) and 0.79 to 0.97 (Greek version).39 (source 39, abstract source only) In knee osteoarthritis, findings on test-retest reliability are mixed, and the stiffness subscale may not be reliable enough for use with individual patients.37 (source 37, full paper)
Smallest change that matters (MIC)After hip replacement, minimal clinically important differences ranged from 8.3 to 41.0 for pain and from 9.7 to 34.0 for function (converted to 0 to 100, where 0 is best) across studies and methods.40 (source 40, abstract source only)
Measurement errorThe 2011 review reports that the minimal detectable change varies by condition and subscale.37 We found no detectable change for hip problems that we could compare with the important change. (source 37, full paper)

The HOOS was developed from the WOMAC.54 (source 54, abstract source only)

In knee osteoarthritis, a 2011 review found mixed findings on its test-retest reliability.37 (source 37, full paper)

The WOMAC is also listed on the knee page.

Forgotten Joint Score (FJS-12)Twelve questions on how aware people are of their joint in daily life, built for people after joint replacement and rated within that group.

Evidence: Moderate, rated within people after hip or knee joint replacement, the group it was built for (studies disagree on measurement error). A 2020 COSMIN review found strong evidence of good test-retest reliability (intraclass correlation coefficient 0.8 or more in all studies), but conflicting results for measurement error.42 After hip replacement, the detectable change (8 points, 90% confidence) was smaller than the important change for one patient (18 points).43

What it measuresHow aware people are of their artificial joint during everyday tasks; higher awareness means a worse result.44 (source 44, full paper)
Tested inPeople after hip or knee replacement (13 studies in a 2020 review);42 461 people six months after hip replacement in the UK;43 and people after hip replacement (Italian version).44 (source 42, abstract source only; source 43, abstract source only; source 44, full paper)
Items and scoring12 questions, each with five response options; the summed score is converted to 0 to 100, where a higher score means a better result (less awareness of the joint).44 (source 44, full paper)
Free or licensedLicence terms not confirmed: we found no page from the owner stating them, so no link is given.
ReliabilityTest-retest reliability (ICC) 0.8 or more in all studies, with strong evidence (2020 review).42 (source 42, abstract source only)
Smallest change that matters (MIC)After hip replacement: minimal important change 18 points for one patient and 17.7 points for a group; minimal clinically important difference 8.1 points between groups.43 (source 43, abstract source only)
Measurement errorMinimal detectable change (90% confidence) 8 points after hip replacement.43 (source 43, abstract source only) The 2020 review found conflicting results for measurement error across studies.42 (source 42, abstract source only)

The Forgotten Joint Score is also listed on the knee page, where studies disagree on whether the detectable change after knee replacement is smaller than the important change.

Reviewed but not includedOther questionnaires we checked, and why they are not listed above.
Harris Hip Score and modified Harris Hip Score (mHHS)Reason not included: a 2015 COSMIN review found too little information, or only poor-quality studies, to evaluate the questionnaires other than the HAGOS, HOS and iHOT;1 a 2020 international consensus recommended the HAGOS and iHOT instead;2 and after hip arthroscopy the modified score had reduced measurement properties and a ceiling effect.4 The original Harris Hip Score also includes clinical test items; the modified version leaves out those last two items.24 (source 1, abstract source only; source 2, abstract source only; source 4, abstract source only; source 24, full paper)
Non-Arthritic Hip ScoreReason not included: a 2015 COSMIN review could not fully evaluate it because of missing information or poor-quality studies,1 and a 2015 review of hip preservation surgery rated the HOS, HAGOS and iHOT-33 better.48 (source 1, abstract source only; source 48, abstract source only)
Lequesne indexReason not included: in hip osteoarthritis its reliability was lower than the WOMAC’s in a Turkish study (intraclass correlation coefficient 0.51 to 0.85)38 and similar to it in a Greek study (0.57 to 0.98),39 and we found no systematic review of its measurement properties that supports it in hip problems. (source 38, abstract source only; source 39, abstract source only)
HOOS physical function short form (HOOS-PS)Reason not included: a 2020 COSMIN review found moderate-quality evidence of sufficient reliability (pooled reliability (ICC) 0.86, 142 people), but high-quality evidence of insufficient construct validity and inconsistent content validity, and advised using it only with great caution.45 (source 45, full paper)
HOOS-12 and HOOS JR (joint replacement)Reason not included: we found no systematic review of their reliability.
Lower Extremity Functional Scale (LEFS)Reason not included: a 2016 review of 27 studies found reliability 0.85 to 0.998 for retests within 1 to 7 days (intraclass or Pearson correlation; intraclass alone 0.88 to 0.998), and 0.75 to 0.90 over longer gaps, a pooled detectable change of 6 points (90% confidence; individual studies 8.1 to 15.2) and an important change of 9 points,55 and a 2016 review of hip and knee replacement questionnaires ranked it second among lower-limb measures, after the WOMAC.26 It covers the whole leg rather than the hip, so it is on the whole-body page. (source 55, full paper; source 26, full paper)
Numerical pain rating scale (0 to 10) for the hipReason not included: the international core domain set for hip and knee osteoarthritis (2019) names pain as a core domain but had not yet recommended which instrument to use,46 and we found no systematic review of the 0 to 10 scale’s measurement properties in hip problems. (source 46, abstract source only) It is listed on the low back page (recommended by the core outcome set) and the neck page (supported by a review in neck pain); it is left out here because no review supports it in hip problems.

All outcome measures · Other regions: Low back · Neck · Shoulder · Elbow · Wrist and hand · Knee · Ankle and foot · Whole body

These are findings from the cited studies, not instructions. The page is not a complete review of every outcome measure and is not a clinical protocol. Questionnaires that need a licence are described here but not reproduced; use the official copy and follow its conditions of use. The page is written for registered health practitioners and students, who remain responsible for their own clinical decisions; it is not advice for patients. See the terms of use.

Last checked against the cited sources: 14 November 2026.

Get the book for the examination itself

Rule It In, Rule It Out works through the examination of each body region: the red flags to screen first, then the special tests, with the published figures for each test and how to read them.

Look inside the book: free sample pages

Coming November 2026: 330 pages, paperback and PDF. Launch offer: subscribers get the PDF for A$39 instead of A$49, for the first two weeks after publication. Be first to know at launch

Sources (55)Each figure above is cited to a published source; figures checked only against an abstract are labelled abstract source only.
  1. Thorborg K, Tijssen M, Habets B, et al. Patient-Reported Outcome (PRO) questionnaires for young to middle-aged adults with hip and groin disability: a systematic review of the clinimetric evidence. Br J Sports Med. 2015;49(12):812. Abstract source only. Link
  2. Impellizzeri FM, Jones DM, Griffin D, et al. Patient-reported outcome measures for hip-related pain: a review of the available evidence and a consensus statement from the International Hip-related Pain Research Network, Zurich 2018. Br J Sports Med. 2020;54(14):848-857. Abstract source only. Link
  3. Thorborg K, Hölmich P, Christensen R, Petersen J, Roos EM. The Copenhagen Hip and Groin Outcome Score (HAGOS): development and validation according to the COSMIN checklist. Br J Sports Med. 2011;45(6):478-491. Abstract source only. Link
  4. Kemp JL, Collins NJ, Roos EM, Crossley KM. Psychometric properties of patient-reported outcome measures for hip arthroscopic surgery. Am J Sports Med. 2013;41(9):2065-2073. Abstract source only. Link
  5. Thomeé R, Jónasson P, Thorborg K, et al. Cross-cultural adaptation to Swedish and validation of the Copenhagen Hip and Groin Outcome Score (HAGOS) for pain, symptoms and physical function in patients with hip and groin disability due to femoro-acetabular impingement. Knee Surg Sports Traumatol Arthrosc. 2014;22(4):835-842. Abstract source only. Link
  6. Giezen H, Stevens M, van den Akker-Scheek I, Reininga IHF. Validity and reliability of the Dutch version of the Copenhagen Hip And Groin Outcome Score (HAGOS-NL) in patients with hip pathology. PLoS One. 2017;12(10):e0186064. Full paper. Link
  7. Mendonça LM, Camelo PRP, Trevisan GCC, et al. The Brazilian hip and groin outcome score (HAGOS-Br): cross-cultural adaptation and measurement properties. Braz J Phys Ther. 2021;25(6):874-882. Abstract source only. Link
  8. Dede BT, Oğuz M, Ada A, et al. Validity, reliability, and interpretability of the Turkish version of the Copenhagen Hip and Groin Outcome Score (HAGOS). Disabil Rehabil. 2026 (online ahead of print). Abstract source only. Link
  9. Christensen KB, Thorborg K, Kierkegaard-Brøchner S, et al. Psychometric validation of the Copenhagen Hip and Groin Outcome Score (HAGOS) and Oxford Hip Score (OHS) in patients with hip-abductor tendon pathology. Br J Sports Med. 2025;59(9):651-658. Abstract source only. Link
  10. Mohtadi NG, Griffin DR, Pedersen ME, et al. The development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33). Arthroscopy. 2012;28(5):595-605. Abstract source only. Link
  11. Scholes MJ, King MG, Crossley KM, et al. The validity, reliability, and responsiveness of the International Hip Outcome Tool-33 (iHOT-33) in patients with hip and groin pain treated without surgery. Am J Sports Med. 2021;49(10):2677-2688. Abstract source only. Link
  12. Angilecchia D, Ugolini A, Cacciola F, et al. Direct comparison of the international hip outcome tool (iHOT-33) and its short version (iHOT-12) in patients with symptomatic hip disorders: a structural and construct validity and reliability study. Physiother Theory Pract. 2026 (online ahead of print). Abstract source only. Link
  13. Lertwanich P, Loog-In S, Pornrattanamaneewong C, Ganokroj P. Validity and reliability of the Thai version of the International Hip Outcome Tool in young to middle-aged physically active adults with hip disorders. Orthop J Sports Med. 2021;9(9):23259671211042017. Full paper. Link
  14. Griffin DR, Parsons N, Mohtadi NG, Safran MR. A short version of the International Hip Outcome Tool (iHOT-12) for use in routine clinical practice. Arthroscopy. 2012;28(5):611-616. Abstract source only. Link
  15. Baumann F, Popp D, Müller K, et al. Validation of a German version of the International Hip Outcome Tool 12 (iHOT12) according to the COSMIN checklist. Health Qual Life Outcomes. 2016;14:3. Full paper. Link
  16. Nwachukwu BU, Chang B, Beck EC, et al. How should we define clinically significant outcome improvement on the iHOT-12? HSS J. 2019;15(2):103-108. Abstract source only. Link
  17. González-de-la-Flor Á, López-de-Uralde-Villanueva I, Valera-Calero JA, et al. Validity and test-retest reliability of the Spanish version of the International Hip Outcome Tool (iHOT-12Sv). J Clin Med. 2022;11(21):6232. Full paper. Link
  18. Martin RL, Philippon MJ. Evidence of reliability and responsiveness for the hip outcome score. Arthroscopy. 2008;24(6):676-682. Abstract source only. Link
  19. Seijas R, Sallent A, Ruiz-Ibán MA, et al. Validation of the Spanish version of the Hip Outcome Score: a multicenter study. Health Qual Life Outcomes. 2014;12:70. Full paper. Link
  20. Röling MA, Hesseling B, Jansen SPL, Bloem RM, Mathijssen NMC. Validation of the Dutch version of the Hip Outcome Score; validity, reliability, and responsiveness in patients with femoroacetabular impingement syndrome. J Hip Preserv Surg. 2021;8(3):298-304. Full paper. Link
  21. Korakakis V, Whiteley R, Kotsifaki A, et al. A systematic review evaluating the clinimetric properties of the Victorian Institute of Sport Assessment (VISA) questionnaires for lower limb tendinopathy shows moderate to high-quality evidence for sufficient reliability, validity and responsiveness - part II. Knee Surg Sports Traumatol Arthrosc. 2021;29(9):2765-2788. Full paper. Link
  22. Nasser AM, Fearon AM, Grimaldi A, et al. Outcome measures in the management of gluteal tendinopathy: a systematic review of their measurement properties. Br J Sports Med. 2022;56(15):877-887. Abstract source only. Link
  23. Ebert JR, Fearon AM, Smith A, Janes GC. Responsiveness of the Victorian Institute for Sport Assessment for Gluteal Tendinopathy (VISA-G), modified Harris hip and Oxford hip scores in patients undergoing hip abductor tendon repair. Musculoskelet Sci Pract. 2019;43:1-5. Abstract source only. Link
  24. Sveinall H, Wenstad PK, Fearon AM, et al. The reliability and validity of the Norwegian version of the Victorian Institute of Sports Assessment for gluteal tendinopathy questionnaire (VISA-G-Norwegian) for patients with greater trochanteric pain syndrome. BMC Musculoskelet Disord. 2023;24(1):769. Full paper. Link
  25. Fearon AM, Grimaldi A, Mellor R, et al. ICON 2020-International Scientific Tendinopathy Symposium Consensus: the development of a core outcome set for gluteal tendinopathy. Br J Sports Med. 2024;58(5):245-254. Abstract source only. Link
  26. Harris K, Dawson J, Gibbons E, et al. Systematic review of measurement properties of patient-reported outcome measures used in patients undergoing hip and knee arthroplasty. Patient Relat Outcome Meas. 2016;7:101-108. Full paper. Link
  27. Gagnier JJ, Huang H, Mullins M, et al. Measurement properties of patient-reported outcome measures used in patients undergoing total hip arthroplasty: a systematic review. JBJS Rev. 2018;6(1):e2. Abstract source only. Link
  28. Beard DJ, Harris K, Dawson J, et al. Meaningful changes for the Oxford hip and knee scores after joint replacement surgery. J Clin Epidemiol. 2015;68(1):73-79. Full paper. Link
  29. Naal FD, Sieverding M, Impellizzeri FM, et al. Reliability and validity of the cross-culturally adapted German Oxford hip score. Clin Orthop Relat Res. 2009;467(4):952-957. Abstract source only. Link
  30. Martín-Fernández J, Gray-Laymón P, Molina-Siguero A, et al. Cross-cultural adaptation and validation of the Spanish version of the Oxford Hip Score in patients with hip osteoarthritis. BMC Musculoskelet Disord. 2017;18(1):205. Abstract source only. Link
  31. Harris LK, Troelsen A, Terluin B, et al. Interpretation threshold values for the Oxford Hip Score in patients undergoing total hip arthroplasty: advancing their clinical use. J Bone Joint Surg Am. 2023;105(10):797-804. Abstract source only. Link
  32. Oxford University Innovation. The Oxford Hip Score (OHS): licence details. Full page. Link
  33. Oxford University Innovation, Clinical Outcomes. Licence request process and fees. Full page. Link
  34. Gojło MK, Paradowski PT. Polish adaptation and validation of the hip disability and osteoarthritis outcome score (HOOS) in osteoarthritis patients undergoing total hip replacement. Health Qual Life Outcomes. 2020;18(1):135. Full paper. Link
  35. Chéret EPBM, Mechlenburg I, Skou ST, et al. Minimal important change in the Hip Disability and Osteoarthritis Outcome Score and the European Quality of Life 5 Dimensions in adults with hip osteoarthritis after 12 weeks of exercise. Musculoskelet Sci Pract. 2025;76:103274. Abstract source only. Link
  36. Roos EM. KOOS, HOOS and related questionnaires: copyright, permission and fees (official information page). Full page. Link
  37. Collins NJ, Misra D, Felson DT, Crossley KM, Roos EM. Measures of knee function: IKDC Subjective Knee Evaluation Form, KOOS, KOOS-PS, KOS-ADL, Lysholm Knee Scoring Scale, Oxford Knee Score, Tegner Activity Score, and WOMAC. Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S208-S228. Full paper. Link
  38. Basaran S, Guzel R, Seydaoglu G, Guler-Uysal F. Validity, reliability, and comparison of the WOMAC osteoarthritis index and Lequesne algofunctional index in Turkish patients with hip or knee osteoarthritis. Clin Rheumatol. 2010;29(7):749-756. Abstract source only. Link
  39. Konstantinidis GA, Aletras VH, Kanakari KA, et al. Comparative validation of the WOMAC osteoarthritis and Lequesne algofunctional indices in Greek patients with hip or knee osteoarthritis. Qual Life Res. 2014;23(2):539-548. Abstract source only. Link
  40. MacKay C, Clements N, Wong R, Davis AM. A systematic review of estimates of the minimal clinically important difference and patient acceptable symptom state of the Western Ontario and McMaster Universities Osteoarthritis Index in patients who underwent total hip and total knee replacement. Osteoarthritis Cartilage. 2019;27(10):1408-1419. Abstract source only. Link
  41. Bellamy N. WOMAC 3.1 Index (developer’s web page). Full page. Link
  42. Adriani M, Malahias MA, Gu A, et al. Determining the validity, reliability, and utility of the Forgotten Joint Score: a systematic review. J Arthroplasty. 2020;35(4):1137-1144. Abstract source only. Link
  43. Robinson PG, MacDonald DJ, Macpherson GJ, Patton JT, Clement ND. Changes and thresholds in the Forgotten Joint Score after total hip arthroplasty: minimal clinically important difference, minimal important and detectable changes, and patient-acceptable symptom state. Bone Joint J. 2021;103-B(12):1759-1765. Abstract source only. Link
  44. Longo UG, De Salvatore S, Santamaria G, et al. Total hip replacement: psychometric validation of the Italian version of Forgotten Joint Score (FJS-12). J Clin Med. 2023;12(4):1525. Full paper. Link
  45. Braaksma C, Wolterbeek N, Veen MR, Prinsen CAC, Ostelo RWJG. Systematic review and meta-analysis of measurement properties of the Hip disability and Osteoarthritis Outcome Score - Physical Function Shortform (HOOS-PS) and the Knee Injury and Osteoarthritis Outcome Score - Physical Function Shortform (KOOS-PS). Osteoarthritis Cartilage. 2020;28(12):1525-1538. Full paper. Link
  46. Smith TO, Hawker GA, Hunter DJ, et al. The OMERACT-OARSI core domain set for measurement in clinical trials of hip and/or knee osteoarthritis. J Rheumatol. 2019;46(8):981-989. Abstract source only. Link
  47. Australian Commission on Safety and Quality in Health Care. Patient-Reported Outcome Measure Recommendations for Low Back Pain. Sydney: ACSQHC; September 2024. Table 8 (COSMIN rating criteria). Full document. Link
  48. Ramisetty N, Kwon Y, Mohtadi N. Patient-reported outcome measures for hip preservation surgery: a systematic review of the literature. J Hip Preserv Surg. 2015;2(1):15-27. Abstract source only. Link
  49. Migliorini F, Maffulli N, Schäfer L, et al. Minimal clinically important difference (MCID), patient-acceptable state (PASS), minimally detectable change (MDC), and substantial clinical benefit (SCB) in patients who have undergone arthroscopic surgery for femoroacetabular impingement: a systematic review. J Orthop Traumatol. 2026;27(1):34. Table 2 (HAGOS rows, from minimal important change studies). Full paper. Link
  50. Tijssen M, Tak I, Stubbe J, et al. Translation, cross-cultural adaptation, and validation of the Dutch International Hip Outcome Tool-33 (iHOT-33 NL) in young, physically active individuals with symptomatic hip joint pathology. J Orthop Sports Phys Ther. 2018;48(4):289-298. Full paper. Link
  51. Watanabe N, Murakami S, Uchida S, et al. Exploring the validation of a Japanese version of the International Hip Outcome Tool 12: reliability, validity, and responsiveness. J Orthop Sci. 2019;24(4):652-657. Abstract source only. Link
  52. Dion MO, Simonyan D, Faure PA, et al. Validation of the French version of the Self-Administered International Hip Outcome Tool-12 Questionnaire and determination of the Minimal Clinically Important Difference (MCID) in the French speaking population. Orthop Traumatol Surg Res. 2021;107(8):103083. Abstract source only. Link
  53. Gökşen A, Çaylak R, Çekok FK, Kahraman T. Translation, cross-cultural adaptation, reliability, and convergent and known-group validity of the Turkish full version of the Hip Disability and Osteoarthritis Outcome Score in patients with hip osteoarthritis. Arch Rheumatol. 2024;39(2):180-193. Table 2. Full paper. Link
  54. Klässbo M, Larsson E, Mannevik E. Hip disability and osteoarthritis outcome score. An extension of the Western Ontario and McMaster Universities Osteoarthritis Index. Scand J Rheumatol. 2003;32(1):46-51. Abstract source only. Link
  55. Mehta SP, Fulton A, Quach C, et al. Measurement properties of the Lower Extremity Functional Scale: a systematic review. J Orthop Sports Phys Ther. 2016;46(3):200-216. Full paper. Link

One study, one test, once a month

Rule It In is a free evidence letter for musculoskeletal clinicians: one recent study explained, one examination test with its real numbers. From Trokos, publisher of Rule It In, Rule It Out.

Free when you confirm your email: a one-page PDF of the strongest special tests to rule in and rule out, with tests that carry a caution flagged separately.

Launch offer for subscribers: the PDF edition of Rule It In, Rule It Out for A$39 instead of A$49, for the first two weeks after publication. Sign up free to get the code on launch day.